FNIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.161200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.744000E-01
Normal-vs-Stage2
9.251200E-01
Normal-vs-Stage3
5.675800E-01
Normal-vs-Stage4
1.781160E-01
Stage1-vs-Stage2
7.806000E-01
Stage1-vs-Stage3
3.644400E-01
Stage1-vs-Stage4
1.811990E-01
Stage2-vs-Stage3
4.445400E-01
Stage2-vs-Stage4
6.204400E-02
Stage3-vs-Stage4
6.436200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.628800E-01
Normal-vs-AfricanAmerican
5.235400E-01
Normal-vs-Asian
7.586000E-01
Caucasian-vs-AfricanAmerican
3.765000E-01
Caucasian-vs-Asian
5.264800E-01
AfricanAmerican-vs-Asian
2.853800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.209000E-01
Normal-vs-Female
9.149000E-01
Male-vs-Female
9.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.796400E-01
Normal-vs-Age(41-60Yrs)
6.695600E-01
Normal-vs-Age(61-80Yrs)
9.464800E-01
Normal-vs-Age(81-100Yrs)
7.105600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.462600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.617200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.829200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.775600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.762020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.400400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.052800E-01
Normal-vs-Daily Drinker
4.092800E-01
Normal-vs-Weekly Drinker
9.022000E-01
Normal-vs-Occasional Drinker
7.847800E-01
Normal-vs-Social Drinker
7.578800E-01
Non Drinker-vs-Daily Drinker
3.431000E-01
Non Drinker-vs-Weekly Drinker
3.919200E-01
Non Drinker-vs-Occasional Drinker
2.050800E-01
Non Drinker-vs-Social Drinker
2.028800E-01
Daily Drinker-vs-Weekly Drinker
1.422380E-01
Daily Drinker-vs-Occasional Drinker
8.332300E-02
Daily Drinker-vs-Social Drinker
5.974500E-02
Weekly Drinker-vs-Occasional Drinker
7.880600E-01
Weekly Drinker-vs-Social Drinker
7.631200E-01
Occasional Drinker-vs-Social Drinker
9.716600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.426360E-01
Normal-vs-Grade 2
6.466400E-02
Normal-vs-Grade 3
7.959600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.212800E-01
Grade 1-vs-Grade 3
5.984800E-01
Grade 1-vs-Grade 4
1.426360E-01
Grade 2-vs-Grade 3
7.477800E-01
Grade 2-vs-Grade 4
6.466400E-02
Grade 3-vs-Grade 4
7.959600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.319000E-01
Normal-vs-NonDiabetic
9.678600E-01
Diabetic-vs-NonDiabetic
8.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.842800E-01
Normal-vs-NoPancreatitis
9.814800E-01
Pancreatitis-vs-NoPancreatitis
3.805200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.276000E-01
Normal-vs-N1
8.925600E-01
N0-vs-N1
8.908400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.991600E-01
Normal-vs-TP53-NonMutant
7.957200E-01
TP53-Mutant-vs-TP53-NonMutant
1.917180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
